169 Programs
-
Second Opinion
Integrating Novel Approaches into the Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
-
-
A
-
M
-
S
- +1
-
A
-
-
ASH Proceedings 2025
Recent Developments in the Management of Relapsed/Refractory Multiple Myeloma from ASH 2025: BCMA-Targeted Therapy and Investigational Agents
-
-
S
-
S
-
-
S
-
S
-
-
5-Minute Journal Club
Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays in the Treatment of Breast Cancer
-
-
L
-
L
-
-
Oncology Today with Dr Neil Love
Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia
-
-
B
-
B
-
-
B
-
B
-